BiotechTube
Home/Advent Therapeutics/David L. Lopez, Esq., CPA
DL

David L. Lopez, Esq., CPA

CEO and co-founder

Advent Therapeutics

Therapeutic Areas

NeonatologyRare DiseasesPulmonology

Advent Therapeutics Pipeline

DrugIndicationPhase
Vitamin A Palmitate (IM)Bronchopulmonary Dysplasia (BPD)Unknown
Vitamin A Palmitate (Aerosolized)Bronchopulmonary Dysplasia (BPD)Unknown
Vitamin A Palmitate PlatformRetinopathy of Prematurity (ROP)Unknown

Leadership Team at Advent Therapeutics

CG
Craig Gelfand, PhD
Head of R&D
RS
Robert Segal, MD, FACP
CMO and co-founder
JM
Jan Mazela, MD, PhD
Chief Medical Advisor and co-founder
View full Advent Therapeutics profile